XML 65 R64.htm IDEA: XBRL DOCUMENT v3.2.0.727
Guarantor Financial Information (Condensed Consolidated Statements of Cash Flows) (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jul. 04, 2015
Jun. 28, 2014
Jul. 04, 2015
Jun. 28, 2014
Cash flows from operating activities:        
Net income/(loss) $ 4,937 $ 34,575 $ 6,761 $ (16,431)
Earnings in investments in subsidiaries 0 0 0 0
Other operating cash flows     180,789 57,455
Net cash provided by operating activities     187,550 41,024
Cash flows from investing activities:        
Capital expenditures     (98,722) (103,531)
Acquisitions, net of cash acquired     0 (2,075,651)
Investment in unconsolidated subsidiary     0 0
Note receivable from affiliates     0 0
Gross proceeds from disposal of property, plant and equipment and other assets     1,484 2,308
Proceeds from insurance settlement     341 0
Payments related to routes and other intangibles     (2,242) (7,312)
Net cash used by investing activities     (99,139) (2,184,186)
Cash flows from financing activities:        
Proceeds from long-term debt     579,974 1,821,196
Payments on long-term debt     (583,736) (287,066)
Borrowings from revolving credit facility     41,244 170,143
Payments on revolving credit facility     (83,506) (257,254)
Net cash overdraft financing     (880) 9,529
Deferred loan costs     (11,629) (44,865)
Issuance of common stock     171 417
Contributions from parent     0 0
Minimum withholding taxes paid on stock awards     (4,775) (5,495)
Excess tax benefits from stock-based compensation     (12) 1,329
Distributions to noncontrolling interests     (1,866) 0
Net cash provided/(used) by financing activities     (65,015) 1,407,934
Effect of exchange rate changes on cash     (6,160) 8,156
Net increase/(decrease) in cash and cash equivalents     17,236 (727,072)
Cash and cash equivalents at beginning of period     108,784 870,857
Cash and cash equivalents at end of period 126,020 143,785 126,020 143,785
Parent [Member]        
Cash flows from operating activities:        
Net income/(loss) 4,937 34,575 6,761 (16,431)
Earnings in investments in subsidiaries (18,444) (57,688) (35,893) (69,049)
Other operating cash flows     100,687 81,867
Net cash provided by operating activities     71,555 (3,613)
Cash flows from investing activities:        
Capital expenditures     (21,187) (22,570)
Acquisitions, net of cash acquired     0 0
Investment in unconsolidated subsidiary     (20) (1,483,007)
Note receivable from affiliates     0 0
Gross proceeds from disposal of property, plant and equipment and other assets     705 1,041
Proceeds from insurance settlement     71 0
Payments related to routes and other intangibles     0 (7,312)
Net cash used by investing activities     (20,431) (1,511,848)
Cash flows from financing activities:        
Proceeds from long-term debt     0 1,100,000
Payments on long-term debt     (8,067) (252,500)
Borrowings from revolving credit facility     8,000 122,445
Payments on revolving credit facility     (52,000) (207,445)
Net cash overdraft financing     0 0
Deferred loan costs     (1,525) (41,390)
Issuance of common stock     171 417
Contributions from parent     0 0
Minimum withholding taxes paid on stock awards     (4,775) (5,495)
Excess tax benefits from stock-based compensation     (12) 1,329
Distributions to noncontrolling interests     0  
Net cash provided/(used) by financing activities     (58,208) 717,361
Effect of exchange rate changes on cash     0 0
Net increase/(decrease) in cash and cash equivalents     (7,084) (798,100)
Cash and cash equivalents at beginning of period     10,447 857,267
Cash and cash equivalents at end of period 3,363 59,167 3,363 59,167
Guarantors [Member]        
Cash flows from operating activities:        
Net income/(loss) 18,110 50,670 36,860 85,300
Earnings in investments in subsidiaries 0 0 0 0
Other operating cash flows     (32,359) (36,376)
Net cash provided by operating activities     4,501 48,924
Cash flows from investing activities:        
Capital expenditures     (38,383) (38,730)
Acquisitions, net of cash acquired     0 (645)
Investment in unconsolidated subsidiary     (29,541) (2,217,686)
Note receivable from affiliates     51,019 (204,074)
Gross proceeds from disposal of property, plant and equipment and other assets     545 615
Proceeds from insurance settlement     270 0
Payments related to routes and other intangibles     0 0
Net cash used by investing activities     (16,090) (2,460,520)
Cash flows from financing activities:        
Proceeds from long-term debt     0 0
Payments on long-term debt     (41) (43)
Borrowings from revolving credit facility     0 0
Payments on revolving credit facility     0 0
Net cash overdraft financing     0 0
Deferred loan costs     0 0
Issuance of common stock     0 0
Contributions from parent     0 2,421,762
Minimum withholding taxes paid on stock awards     0 0
Excess tax benefits from stock-based compensation     0 0
Distributions to noncontrolling interests     0  
Net cash provided/(used) by financing activities     (41) 2,421,719
Effect of exchange rate changes on cash     0 0
Net increase/(decrease) in cash and cash equivalents     (11,630) 10,123
Cash and cash equivalents at beginning of period     14,460 6,117
Cash and cash equivalents at end of period 2,830 16,240 2,830 16,240
Non-guarantors [Member]        
Cash flows from operating activities:        
Net income/(loss) 334 7,018 (967) (16,251)
Earnings in investments in subsidiaries 0 0 0 0
Other operating cash flows     112,461 11,964
Net cash provided by operating activities     111,494 (4,287)
Cash flows from investing activities:        
Capital expenditures     (39,152) (42,231)
Acquisitions, net of cash acquired     0 (2,075,006)
Investment in unconsolidated subsidiary     29,541 (2,307,591)
Note receivable from affiliates     (51,019) 204,074
Gross proceeds from disposal of property, plant and equipment and other assets     234 652
Proceeds from insurance settlement     0 0
Payments related to routes and other intangibles     (2,242) 0
Net cash used by investing activities     (62,638) (4,220,102)
Cash flows from financing activities:        
Proceeds from long-term debt     579,974 721,196
Payments on long-term debt     (575,628) (34,523)
Borrowings from revolving credit facility     33,244 47,698
Payments on revolving credit facility     (31,506) (49,809)
Net cash overdraft financing     (880) 9,529
Deferred loan costs     (10,104) (3,475)
Issuance of common stock     0 0
Contributions from parent     20 3,586,522
Minimum withholding taxes paid on stock awards     0 0
Excess tax benefits from stock-based compensation     0 0
Distributions to noncontrolling interests     (1,866)  
Net cash provided/(used) by financing activities     (6,746) 4,277,138
Effect of exchange rate changes on cash     (6,160) 8,156
Net increase/(decrease) in cash and cash equivalents     35,950 60,905
Cash and cash equivalents at beginning of period     83,877 7,473
Cash and cash equivalents at end of period 119,827 68,378 119,827 68,378
Eliminations [Member]        
Cash flows from operating activities:        
Net income/(loss) (18,444) (57,688) (35,893) (69,049)
Earnings in investments in subsidiaries 18,444 57,688 35,893 69,049
Other operating cash flows     0 0
Net cash provided by operating activities     0 0
Cash flows from investing activities:        
Capital expenditures     0 0
Acquisitions, net of cash acquired     0 0
Investment in unconsolidated subsidiary     20 6,008,284
Note receivable from affiliates     0 0
Gross proceeds from disposal of property, plant and equipment and other assets     0 0
Proceeds from insurance settlement     0 0
Payments related to routes and other intangibles     0 0
Net cash used by investing activities     20 6,008,284
Cash flows from financing activities:        
Proceeds from long-term debt     0 0
Payments on long-term debt     0 0
Borrowings from revolving credit facility     0 0
Payments on revolving credit facility     0 0
Net cash overdraft financing     0 0
Deferred loan costs     0 0
Issuance of common stock     0 0
Contributions from parent     (20) (6,008,284)
Minimum withholding taxes paid on stock awards     0 0
Excess tax benefits from stock-based compensation     0 0
Distributions to noncontrolling interests     0  
Net cash provided/(used) by financing activities     (20) (6,008,284)
Effect of exchange rate changes on cash     0 0
Net increase/(decrease) in cash and cash equivalents     0 0
Cash and cash equivalents at beginning of period     0 0
Cash and cash equivalents at end of period $ 0 $ 0 $ 0 $ 0